HSA Approval

APO-DIMENHYDRINATE TABLET 50 mg

Approval Number

SIN02519P

Drug Name

Product Name

APO-DIMENHYDRINATE TABLET 50 mg

Approval Date

April 17, 1989

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Pharmacy Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

A04AD

ATC Item Name

其它镇吐药

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

APOTEX INC

Active Ingredients

Ingredient Name

DIMENHYDRINATE BP

Strength

50 mg

Drug MonographDimenhydrinate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

APO-DIMENHYDRINATE TABLET 50 mg - HSA Approval | MedPath

AI-Powered Research

Premium Access

APO-DIMENHYDRINATE TABLET 50 mg

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal